Annual Accounts Receivable
$20.30 M
+$4.86 M+31.46%
December 31, 2024
Summary
- As of March 13, 2025, URGN annual accounts receivable is $20.30 million, with the most recent change of +$4.86 million (+31.46%) on December 31, 2024.
- During the last 3 years, URGN annual accounts receivable has risen by +$8.59 million (+73.27%).
- URGN annual accounts receivable is now at all-time high.
Performance
URGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$20.30 M
-$2.50 M-10.96%
December 31, 2024
Summary
- As of March 13, 2025, URGN quarterly accounts receivable is $20.30 million, with the most recent change of -$2.50 million (-10.96%) on December 31, 2024.
- Over the past year, URGN quarterly accounts receivable has dropped by -$2.50 million (-10.96%).
- URGN quarterly accounts receivable is now -10.96% below its all-time high of $22.80 million, reached on September 30, 2024.
Performance
URGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
URGN Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.5% | -11.0% |
| 3 y3 years | +73.3% | +73.3% |
| 5 y5 years | +100.0% | +100.0% |
URGN Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.3% | -11.0% | +115.3% |
| 5 y | 5-year | at high | -100.0% | -11.0% | -100.0% |
| alltime | all time | at high | -100.0% | -11.0% | -100.0% |
UroGen Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $20.30 M(+31.5%) | $20.30 M(-11.0%) |
| Sep 2024 | - | $22.80 M(+30.9%) |
| Jun 2024 | - | $17.41 M(+23.0%) |
| Mar 2024 | - | $14.16 M(-8.3%) |
| Dec 2023 | $15.44 M(+21.6%) | $15.44 M(+20.2%) |
| Sep 2023 | - | $12.85 M(-17.1%) |
| Jun 2023 | - | $15.51 M(+24.1%) |
| Mar 2023 | - | $12.49 M(-1.7%) |
| Dec 2022 | $12.70 M(+8.4%) | $12.70 M(+34.7%) |
| Sep 2022 | - | $9.43 M(-18.7%) |
| Jun 2022 | - | $11.60 M(+22.1%) |
| Mar 2022 | - | $9.50 M(-18.9%) |
| Dec 2021 | $11.72 M | $11.72 M(+50.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $7.78 M(-18.2%) |
| Jun 2021 | - | $9.51 M(+51.0%) |
| Mar 2021 | - | $6.30 M(-10.6%) |
| Dec 2020 | $7.05 M(>+9900.0%) | $7.05 M(+150.8%) |
| Sep 2020 | - | $2.81 M(+599.0%) |
| Jun 2020 | - | $402.00 K(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $112.00 K(-51.7%) |
| Jun 2018 | - | $232.00 K(+5700.0%) |
| Mar 2018 | - | $4000.00(-88.2%) |
| Sep 2017 | - | $34.00 K(+240.0%) |
| Jun 2017 | - | $10.00 K(-88.0%) |
| Dec 2016 | $83.00 K(>+9900.0%) | $83.00 K |
| Dec 2015 | $0.00 | - |
FAQ
- What is UroGen Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for UroGen Pharma?
- What is UroGen Pharma annual accounts receivable year-on-year change?
- What is UroGen Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for UroGen Pharma?
- What is UroGen Pharma quarterly accounts receivable year-on-year change?
What is UroGen Pharma annual accounts receivable?
The current annual accounts receivable of URGN is $20.30 M
What is the all time high annual accounts receivable for UroGen Pharma?
UroGen Pharma all-time high annual accounts receivable is $20.30 M
What is UroGen Pharma annual accounts receivable year-on-year change?
Over the past year, URGN annual accounts receivable has changed by +$4.86 M (+31.46%)
What is UroGen Pharma quarterly accounts receivable?
The current quarterly accounts receivable of URGN is $20.30 M
What is the all time high quarterly accounts receivable for UroGen Pharma?
UroGen Pharma all-time high quarterly accounts receivable is $22.80 M
What is UroGen Pharma quarterly accounts receivable year-on-year change?
Over the past year, URGN quarterly accounts receivable has changed by -$2.50 M (-10.96%)